GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-MER Medical Holdings Ltd (HKSE:03309) » Definitions » Sloan Ratio %

C-MER Medical Holdings (HKSE:03309) Sloan Ratio % : -3.16% (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is C-MER Medical Holdings Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

C-MER Medical Holdings's Sloan Ratio for the quarter that ended in Jun. 2024 was -3.16%.

As of Jun. 2024, C-MER Medical Holdings has a Sloan Ratio of -3.16%, indicating the company is in the safe zone and there is no funny business with accruals.


C-MER Medical Holdings Sloan Ratio % Historical Data

The historical data trend for C-MER Medical Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-MER Medical Holdings Sloan Ratio % Chart

C-MER Medical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 13.97 0.31 -1.96 -

C-MER Medical Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.25 -1.96 -3.16 -

Competitive Comparison of C-MER Medical Holdings's Sloan Ratio %

For the Medical Care Facilities subindustry, C-MER Medical Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-MER Medical Holdings's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, C-MER Medical Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where C-MER Medical Holdings's Sloan Ratio % falls into.


;
;

C-MER Medical Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

C-MER Medical Holdings's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(61.998-361.154
--245.371)/2748.635
=-1.96%

C-MER Medical Holdings's Sloan Ratio for the quarter that ended in Jun. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jun. 2024 )
=(63.003-301.186
--150.523)/2774.331
=-3.16%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. C-MER Medical Holdings's Net Income for the trailing twelve months (TTM) ended in Jun. 2024 was 32.24 (Dec. 2023 ) + 30.763 (Jun. 2024 ) = HK$63 Mil.
C-MER Medical Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2024 was 165.759 (Dec. 2023 ) + 135.427 (Jun. 2024 ) = HK$301 Mil.
C-MER Medical Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2024 was -77.173 (Dec. 2023 ) + -73.35 (Jun. 2024 ) = HK$-151 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-MER Medical Holdings  (HKSE:03309) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jun. 2024, C-MER Medical Holdings has a Sloan Ratio of -3.16%, indicating the company is in the safe zone and there is no funny business with accruals.


C-MER Medical Holdings Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of C-MER Medical Holdings's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


C-MER Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
1-3 Pedder Street, Room 1535, China Construction Building, Central, Hong Kong, HKG
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The Group currently has 70 medical institutions in Hong Kong and the Mainland, including more than 40 specialists and other medical facilities in Hong Kong.
Executives
Lam Shun Chiu Dennis 2201 Interest of corporation controlled by you
Li Xiaoting 2201 Interest of corporation controlled by you
C-mer Group Limited 2101 Beneficial owner

C-MER Medical Holdings Headlines

No Headlines